Cytox
Private company
CYTOX
Cytox Group Limited provides non-invasive, risk assessment and patient stratification tools for Alzheimer's disease and dementia. Cytox’s mission is to transform how new treatments are developed, people are screened, and how patients are managed within the Alzheimer’s disease care pathway..
Founded
2004
2004
Status
Private company
Private company
Geography
United Kingdom based
United Kingdom based
Funding
$15.573 M
$15.573 M
Website
https://cytoxgroup.com
https://cytoxgroup.com
Patents
1
1
Research papers
2
2
Products
genoSCORE
genoSCORE™ combines Cytox’s proprietary technologies variaTECT™, a single nucleotide polymorphism (SNP) profiling array, with SNPfitR™analytical and interpretive software, to give …
genoTOR
genoTOR™ characterises an individual’s genetic profile linked to mTOR-regulated signalling pathways, mechanisms known to affect the risk of Alzheimer's and …
Services
No services posted yet
This data is part of our proprietary analytics report: